BN Business News
Add your company to Business Communicator →

Market regulation · 01/08/1996Updated: 10/18/2026 · 1 min read

Fresenius AG to Divest Hemodialysis Plant in Settlement Over Antitrust Concerns

Summary

Fresenius AG has proposed a consent agreement to settle allegations of unfair business practices, requiring the company to divest a hemodialysis plant in Pennsylvania to Di-Chem, Inc., following its proposed acquisition of National Medical Care, Inc. from W.R. Grace & Co.

Original source language: Federal Register — Federal Trade CommissionOpen original release →

Explore insights

Business insights →